Anal Cancer
Higher Socioeconomic Status Leads to Improved Survival Outcomes in Anal Cancer
March 13, 2018A multivariable analysis revealed how median household income influences cancer-specific and overall survival among patients with squamous cell carcinoma of the anus.
HPV and Cancer (Fact Sheet)
November 02, 2017This fact sheet examines possible links between human papillomaviruses (HPVs) and cancer.
HPV Vaccination Discussions Need to Focus on Education, Awareness
March 13, 2017The top reasons for not initiating HPV vaccination are necessity, safety, and knowledge, rather than a lack of discussions on sexuality.
Nivolumab Shows Promise Against Aggressive Anal Cancer
April 29, 2016Clinical trial results are promising for the use of nivolumab to treat squamous cell carcinoma of the anal canal, according to data presented at the 2016 American Association for Cancer Research Annual Meeting.
High-risk HPV Infection Increases Risk for Anal Cancer
March 07, 2016Anal cancer is associated with human papillomavirus (HPV) infection, and some women are at increased likelihood of have both diseases.
HPV16 seropositivity common before anal cancer diagnosis
February 12, 2015Human papillomavirus type 16 seropositivity is fairly common before an anal cancer diagnosis, according to a study, and seropositivity tends to increase in blood samples drawn closer to time of cancer diagnosis.
HPV16 seropositivity relatively common prior to diagnosis of anal cancer
February 11, 2015Human papillomavirus (HPV) type 16 (HPV16) seropositivity is relatively common in people prior to receiving a diagnosis of anal cancer.
Despite cART, anal cancer risk still high for HIV-infected
December 12, 2012High incidence compared to general population, especially for men who have sex with men.
No benefit of induction chemo, high-dose boost in anal cancer
April 27, 2012Colostomy-free survival not improved in patients with locally advanced anal canal carcinoma.
Cancer risk doubles for organ-transplant recipients
November 21, 2011Compared with the general population, recipients of a kidney, liver, heart, or lung transplant have twice as great a risk for diverse infection-related and unrelated cancers.
HPV vaccine protects men from anal cancer
November 14, 2011A quadrivalent human papillomavirus (HPV) vaccine to prevent anal cancer was shown to be safe and effective in a trial of healthy men who have sex with men.
IMRT a less toxic form of radiation in anal cancer
February 01, 2011A novel chemoradiation regimen for the treatment of anal cancer is proven to have fewer significant side effects than conventional therapy.
HPV vaccine gets nod for prevention of anal cancer
January 03, 2011The FDA has approved the vaccine Gardasil for the prevention of anal cancer and associated precancerous lesions caused by HPV for males and females aged 9 through 26 years.
Sign Up for Free e-newsletters
ONA Articles
- Acrylamide in Food and Cancer Risk (Fact Sheet)
- Skin Cancer Screening Programs: Are They Effective?
- American Association for Cancer Research Releases Its 2018 Annual Report
- High-Dose vs Standard-Dose Flu Vaccine in Elderly Receiving Chemotherapy
- CDC: HPV Vaccination Rates on the Rise Among Adolescents
- Acrylamide in Food and Cancer Risk (Fact Sheet)
- Skin Cancer Screening Programs: Are They Effective?
- Integrating Preoperative Oral Care Into Cancer Treatment Plans
- Myeloablative Conditioning Effective in AML Secondary to MDS/MPN Prior to Allogeneic HCT
- Insurance Status Influences Overall Survival in Follicular Lymphoma
- Culturally Sensitive Navigation Bridges Some Care Gaps for Latino Adults With Advanced Cancer
- Nedaplatin vs Cisplatin for Malignancy-Induced MPE: Noninferior, Less Toxicity
- Prophylactic Cranial Irradiation in Small-Cell Lung Cancer: Update on Patient Selection, Efficacy and Outcomes
- Endocrine Society Released Guidelines for Managing Endocrine Disorders in Childhood Cancer Survivors
- Skin Cancer Screening Programs: Are They Effective?
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
| Bone Cancer | Regimens | Drugs |
| Brain Cancer | Regimens | Drugs |
| Breast Cancer | Regimens | Drugs |
| Endocrine Cancer | Regimens | Drugs |
| Gastrointestinal Cancer | Regimens | Drugs |
| Genitourinary Cancer | Regimens | Drugs |
| Gynecologic Cancer | Regimens | Drugs |
| Head and Neck Cancer | Regimens | Drugs |
| Hematologic Cancer | Regimens | Drugs |
| Lung Cancer | Regimens | Drugs |
| Other Cancers | Regimens | |
| Rare Cancers | Regimens | |
| Skin Cancer | Regimens | Drugs |